BIOGEN INC. — Investor Relations & Filings
Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| ARS | 2026-04-28 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46003499 | 8-K | 2026-05-14 | English | ||
| 46147249 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46147251 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 38512550 | 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 38494955 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 46147256 | ARS | 2026-04-28 | English | ||
| 46147325 | DEFA14A | 2026-04-28 | English | ||
| 46147321 | DEF 14A | 2026-04-28 | English | ||
| 46147329 | Major Shareholding Notification 2026 | 2026-04-07 | English | ||
| 33590958 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-06 | English | ||
| 33122713 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-03-31 | English | ||
| 33052213 | SCHEDULE 13G/A - BIOGEN INC. (0000875045) (Subject) | 2026-03-26 | English | ||
| 46147335 | CURRENT REPORT | 2026-03-11 | English | ||
| 32882744 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
| 32882743 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
BIOGEN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30291/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30291 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30291 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30291 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30291}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOGEN INC. (id: 30291)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.